Associate Director– Translational Pathology and Immunohistochemistry, Translational Sciences and Diagnostics, Translational Medicine

and scientists who integrate tissue-based data into clinical insights that enable the delivery of therapies to the patients most likely to benefit from them. The Associate Director will work closely with other members of this team and with partners within diagnostic sciences, digital pathology and drug discovery and development teams to ensure that strategies for the treatment and cure of disease are based on accurate analysis of pathogenetic mechanisms.

The primary focus of this role is oversight of the design, development and clinical implementation of translational tissue-based biomarker assays. This includes oversight of assay development and data generation both internally and with external vendors to ensure the quality and reliability of data supporting BMS programs.

The successful candidate will be skilled in the integration of IHC data with data from other sources (https://e.g. molecular genetic data, flow cytometry, proteomic data, clinical data, etc.) and will contribute to the assessment and implementation of novel analytic approaches involving digital image analysis, deep learning and other emerging technologies critical to the continued scientific leadership of BMS. The successful candidate will also provide pathology subject matter expertise to clinical trial teams spanning early to late-stage development, and will have opportunities to engage with key academic partners on BMS supported research studies.

Qualifications

• MD or DVM, or their foreign equivalents, and board certification in anatomic pathology
• In addition to an MD or DVM, an advanced degree (MS or PhD) in Biological Sciences or related Biomedical fields is preferred, as is a clear demonstration of high-quality scholarly productivity in a relevant field of biomedical research
• Extensive knowledge of IHC principles and instrumentation
• A minimum of 5 years of relevant work experience
• Experience in monoplex and multiplex IHC (brightfield and fluorescence-based) assay development and IHC stains in tissues
• Experience with in-situ nucleic acid hybridization (RNA/DNA) studies on tissue samples is a plus, as is a working knowledge of basic histomorphology and pathology
• Prior experience working in the fields of oncology, immuno-oncology and immune-related disease pathogenesis is preferred
• Prior experience working in a regulated laboratory setting (CAP/CLIA or other GxP environment) is highly desirable
• Experience with lab information management system implementation and validation is a plus
• Experience with digital image analysis (HALO, ImageJ, Visiopharm, Inform, etc.) of whole-slide histologic and immunohistochemical sections is highly desirable
• Experience in managing people, and a demonstrated ability to drive team achievement is preferred
• Self-motivated and eager to learn new skills and technologies
• Excellent written and verbal communication skills and the ability to clearly communicate scientific objectives and project results are required.

Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. 

Physical presence at the BMS worksite or physical presence in the field is an essential job function of this role which the Company deems critical to collaboration, innovation, productivity, employee well-being and engagement, and enhances the Company culture.

To protect the safety of our workforce, customers, patients and communities, the policy of the Company requires all employees and workers in the https://U.S. and Puerto Rico to be fully vaccinated against COVID-19, unless they have received an exception based on an approved request for a medical or religious reasonable accommodation.  Therefore, all BMS applicants seeking a role located in the https://U.S. and Puerto Rico must confirm that they have already received or are willing to receive the full COVID-19 vaccination by their start date as a qualification of the role and condition of employment.  This requirement is subject to state and local law restrictions and may not be applicable to employees working in certain jurisdictions such as Montana. This requirement is also subject to discussions with collective bargaining representatives in the https://U.S.

Our company is committed to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace adjustments and ongoing support in their roles. Applicants can request an approval of accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application or if you are applying to a role based in the https://U.S. or Puerto Rico and you believe that you are unable to receive a COVID-19 vaccine due to a medical condition or sincerely held religious belief, during or any part of the recruitment process, please direct your inquiries to adastaffingsupport@https://bms.com. Visit https://careers.bms.com/eeo-accessibility to access our complete Equal Employment Opportunity statement.

Any data processed in connection with role applications will be treated in accordance with applicable data privacy policies and regulations.